Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genetics and dilated cardiomyopathy].

E Villard1

  • 1Laboratoire de génétique et insuffisance cardiaque, Association Claude Bernard/Université Paris VI, groupe hospitalier La Pitié-Salpêtrière, pavillon Rambuteau, 47, bd de l'Hôpital, 75651 Paris. villard@chups.jussieu.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 26, 2003
PubMed
Summary

Dilated cardiomyopathy involves heart muscle enlargement and dysfunction, often stemming from genetic factors or a mix of genes and environment. Identifying more genetic causes is key to better patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Transition in kidney transplantation].

Revue medicale suisse·2015
Same author

Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy.

The pharmacogenomics journal·2012
Same author

Plakophilin 2A is the dominant isoform in human heart tissue: consequences for the genetic screening of arrhythmogenic right ventricular cardiomyopathy.

Heart (British Cardiac Society)·2011
Same author

Latent genital tuberculosis in women.

Lyon chirurgical·2010
Same author

Endoscope drying/storage cabinet: interest and efficacy.

The Journal of hospital infection·2007
Same author

A warm layer in Venus' cryosphere and high-altitude measurements of HF, HCl, H2O and HDO.

Nature·2007

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Context:

  • Dilated cardiomyopathy (DCM) is a primary cause of heart transplantation, characterized by ventricular dilatation and dysfunction.
  • Its etiology is complex, with 70% of cases being multifactorial (genetic and environmental) and 30% monogenic (autosomal dominant).
  • A wide spectrum of genetic abnormalities and phenotypic expressions complicates DCM understanding.

Purpose:

  • To explore the genetic underpinnings of dilated cardiomyopathy.
  • To identify novel genes and understand the molecular mechanisms involved in DCM pathogenesis.
  • To enhance the management of patients and their families through improved genetic knowledge.

Summary:

  • Dilated cardiomyopathy (DCM) presents with diverse genetic causes, ranging from multifactorial influences to specific gene mutations.

Related Experiment Videos

  • While numerous genes linked to cardiomyocyte structure have been identified in monogenic DCM, their precise roles remain largely hypothetical.
  • Further research is needed to uncover additional disease-associated genes and elucidate the molecular and physiological pathways driving DCM.

    • Impact:

    • Improved diagnostic accuracy for dilated cardiomyopathy patients and their families.
    • Potential for targeted therapies based on identified genetic defects.
    • Advancement of knowledge in cardiac genetics and disease mechanisms.